Quantcast

Latest Chemokine Stories

2010-05-19 09:49:00

MOUNTAIN VIEW, Calif., May 19 /PRNewswire/ -- ChemoCentryx, Inc., today announced that Thomas J. Schall, Ph.D., the Company's President and Chief Executive Officer is a finalist for the Ernst & Young Entrepreneur Of The Year® 2010 Award in Northern California.

2010-04-08 07:30:00

MOUNTAIN VIEW, Calif., April 8 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it has identified a novel orally available small molecule antagonist of the ChemR23 chemoattractant receptor, CCX832, for clinical development.

2010-03-22 07:30:00

MOUNTAIN VIEW, Calif., March 22 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it has undertaken a Phase II clinical trial of CCX140, a novel, orally-available small molecule compound designed to specifically target the chemokine receptor known as CCR2.

2010-01-28 07:30:00

MOUNTAIN VIEW, Calif., Jan. 28 /PRNewswire/ -- ChemoCentryx, Inc., today announced the initiation of a Phase I clinical trial of CCX168, an orally-administered small molecule designed to treat autoimmune diseases.

2010-01-12 07:00:00

MOUNTAIN VIEW, Calif., Jan. 12 /PRNewswire/ -- ChemoCentryx, Inc., announced today that the Company has appointed Geoffrey M. Parker to the Company's Board of Directors, effective immediately. Mr. Parker is Chief Business Officer of InteKrin Therapeutics, Inc.

2010-01-06 07:30:00

MOUNTAIN VIEW, Calif., Jan. 6 /PRNewswire/ -- ChemoCentryx, Inc., today announced that the executive management team will participate in the 28th Annual J.P. Morgan Healthcare Conference being held January 11 through January 14 in San Francisco at the Westin St. Francis Hotel. Thomas J.

2009-12-16 07:30:00

MOUNTAIN VIEW, Calif., Dec. 16 /PRNewswire/ -- ChemoCentryx, Inc.

2009-07-08 17:39:00

MOUNTAIN VIEW, Calif., July 8 /PRNewswire/ -- ChemoCentryx, Inc. today announced that Thomas J. Schall, Ph.D., ChemoCentryx's President and Chief Executive Officer, will give a keynote lecture at The 9th World Congress on Inflammation in Tokyo, Japan. Dr.

2009-06-15 10:09:24

Up-regulation of certain cytokines and chemokines (signaling molecules involved in the functioning of the immune system) can predict the development of rheumatoid arthritis (RA) three years before the onset of symptoms, according to the results of a new study presented today at EULAR 2009, the Annual Congress of the European League Against Rheumatism in Copenhagen, Denmark.

2009-05-05 07:30:00

Development Candidate Triggers Milestone Payment from GlaxoSmithKline MOUNTAIN VIEW, Calif., May 5 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it has identified an orally bioavailable small molecule antagonist of the C5a receptor, CCX168, as a candidate for clinical development.


Word of the Day
shavie
  • A trick or prank.
The word 'shavie' is related to 'shave'.